Business Context and Reporting Period
This Form 8-K Current Report was filed by Summit Therapeutics Inc. on May 24, 2021. The filing addresses a change in the Company's independent registered public accounting firm, driven by the Company's increasing presence and operations in the United States.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- Dismissal of Auditor: The Audit Committee dismissed PricewaterhouseCoopers LLP, United Kingdom ("PwC UK") as the independent registered public accounting firm.
- Appointment of New Auditor: PricewaterhouseCoopers LLP, United States ("PwC US") was appointed to serve as the independent registered public accounting firm for the year ending December 31, 2021, including interim reviews for the quarters ending June 30, 2021, and September 30, 2021.
- Audit History: Reports by PwC UK for the years ended December 31, 2020, and 2019 contained no adverse opinions, disclaimers, or qualifications.
- Disagreements: There were no disagreements with PwC UK regarding accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the relevant periods.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary risk factor disclosed is the transition of the audit firm, though the Company confirmed no reportable events or disagreements occurred with the outgoing auditor. PwC US was not consulted regarding accounting principles or audit opinions prior to this appointment.
Investor Verification Checklist
- Verify the effective date of the transition from PwC UK to PwC US for the 2021 fiscal year.
- Review the letter from PwC UK (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor upcoming quarterly filings (Q2 and Q3 2021) to ensure PwC US is listed as the auditor.
- Confirm that no undisclosed disagreements or reportable events exist between the Company and PwC UK for the periods ending December 31, 2020, and 2019.